skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:033127/0274   Pages: 6
Recorded: 06/03/2014
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 3
1
Patent #:
Issue Dt:
06/19/2012
Application #:
12148887
Filing Dt:
04/23/2008
Publication #:
Pub Dt:
10/30/2008
Title:
QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS
2
Patent #:
Issue Dt:
07/23/2013
Application #:
13473792
Filing Dt:
05/17/2012
Publication #:
Pub Dt:
09/13/2012
Title:
QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS
3
Patent #:
Issue Dt:
08/26/2014
Application #:
13921396
Filing Dt:
06/19/2013
Publication #:
Pub Dt:
10/24/2013
Title:
QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS
Assignor
1
Exec Dt:
06/01/2014
Assignee
1
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Correspondence name and address
JEFFREY A. HAGENAH
PATENT DEPARTMENT
THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080

Search Results as of: 06/04/2024 05:06 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT